Cytomegalovirus-associated panenteritis in an immunocompetent 60-year-old woman treated with oral valganciclovir: a case report
- PMID: 39852235
- PMCID: PMC11760130
- DOI: 10.1177/03000605241311449
Cytomegalovirus-associated panenteritis in an immunocompetent 60-year-old woman treated with oral valganciclovir: a case report
Abstract
Cytomegalovirus (CMV) infection typically affects immunocompromised individuals. However, CMV-associated enteritis involving the entire small intestine is rare in immunocompetent patients. We report a case of a 60-year-old immunocompetent woman with a history of diabetes mellitus who presented with diarrhea for 3 weeks. Abdominal computed tomography and stool tests revealed panenteritis accompanied by protein-losing enteropathy. Enteroscopy revealed ulcerative mucosa throughout the small intestine, and subsequent biopsies confirmed CMV-associated enteritis. Initial treatment with intravenous ganciclovir was complicated by pancytopenia, leading to its discontinuation and a switch to oral valganciclovir. This adjustment led to significant clinical improvement and symptom resolution. This case highlights the importance of considering CMV-associated enteritis in immunocompetent patients presenting with unexplained gastrointestinal symptoms and demonstrates the effectiveness of oral valganciclovir following ganciclovir-induced pancytopenia.
Keywords: Cytomegalovirus; case report; enteritis; ganciclovir; immunocompetent; pancytopenia; valganciclovir.
Conflict of interest statement
Declaration of conflicting interestThe authors declare that there is no conflict of interest.
Figures



Similar articles
-
Case report: severe cytomegalovirus primary infection in an immunocompetent adult with disseminated intravascular coagulation treated with valganciclovir.BMC Infect Dis. 2016 Jan 19;16:19. doi: 10.1186/s12879-016-1343-3. BMC Infect Dis. 2016. PMID: 26787617 Free PMC article.
-
Fulminant cytomegalovirus myocarditis in an immunocompetent host: resolution with oral valganciclovir.Tex Heart Inst J. 2014 Oct 1;41(5):523-9. doi: 10.14503/THIJ-13-3504. eCollection 2014 Oct. Tex Heart Inst J. 2014. PMID: 25425988 Free PMC article.
-
Similar reduction of cytomegalovirus DNA load by oral valganciclovir and intravenous ganciclovir on pre-emptive therapy after renal and renal-pancreas transplantation.Antivir Ther. 2005;10(1):119-23. Antivir Ther. 2005. PMID: 15751769 Clinical Trial.
-
Reactivated cytomegalovirus proctitis in an immunocompetent patient presenting as nosocomial diarrhea: a case report and literature review.BMC Infect Dis. 2017 Feb 1;17(1):113. doi: 10.1186/s12879-017-2218-y. BMC Infect Dis. 2017. PMID: 28143418 Free PMC article. Review.
-
Valganciclovir for the prevention and treatment of cytomegalovirus disease in immunocompromised hosts.Expert Rev Anti Infect Ther. 2004 Feb;2(1):27-41. doi: 10.1586/14787210.2.1.27. Expert Rev Anti Infect Ther. 2004. PMID: 15482169 Review.
Cited by
-
Cytomegalovirus Proctitis Mimicking Inflammatory Bowel Disease in an Immunocompetent Elderly Patient: A Diagnostic Challenge.Cureus. 2025 Jun 15;17(6):e86042. doi: 10.7759/cureus.86042. eCollection 2025 Jun. Cureus. 2025. PMID: 40666552 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical